Sphera Funds Management’s Ventyx Biosciences VTYX Stock Holding History

Sphera Funds Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-180,114	Closed	-$1.63M	–	119
2025 Q4	$1.63M	Sell	180,114 -260,000	-59%	-$1.94M	0.31%	80
2025 Q3	$1.37M	Sell	440,114 -115,700	-21%	-$307K	0.29%	87
2025 Q2	$1.19M	Sell	555,814 -456,935	-45%	-$738K	0.28%	81
2025 Q1	$1.16M	Hold	1,012,749	–	–	0.27%	86
2024 Q4	$2.22M	Hold	1,012,749	–	–	0.4%	78
2024 Q3	$2.21M	Hold	1,012,749	–	–	0.35%	80
2024 Q2	$2.34M	Buy	1,012,749 +20,000	+2%	+$83.1K	0.32%	84
2024 Q1	$5.46M	Buy	992,749 +812,749	+452%	+$3.72M	0.77%	46
2023 Q4	$445K	Buy	+180,000	New	+$1.71M	0.07%	92

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sphera Funds Management's VTYX Position: Q1 2026 in Review

Sphera Funds Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 180,114 shares — an estimated $1.63M sold.

Sphera Funds Management first reported a position in VTYX in Q4 2023 and held it in 9 quarters. The position peaked at $5.46M in Q1 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Sphera Funds Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Sphera Funds Management sold 180,114 Ventyx Biosciences shares in Q1 2026, an estimated $1.63M.
Sphera Funds Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 9 quarters.
Sphera Funds Management's Ventyx Biosciences position peaked at $5.46M in Q1 2024.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.